Home > News > Accelrys Reports Fiscal 2005 Third-Quarter and Year-to-Date
January 26th, 2005
Accelrys Reports Fiscal 2005 Third-Quarter and Year-to-Date
Abstract:
"I am pleased to report that orders grew during the quarter, and I am confident that we will meet our goal of modest orders growth for the full fiscal year," said Mark Emkjer, president and CEO of Accelrys. "We have made significant progress with the SciTegic acquisition, the expansion of the nanotechnology initiative, and major new releases, including Materials Studio 3.1, while maintaining strong expense control."
Source:
businesswire
Bookmark:
| Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||